查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631518

酒糟治疗市场规模、份额、趋势分析报告：按药物类别、给药方式、地区和细分市场预测，2025-2030 年

Rosacea Treatment Market Size, Share & Trends Analysis Report By Drug Class (Antibiotics, Alpha Agonists, Retinoids, Corticosteroids), By Mode Of Administration (Topical, Oral), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

酒糟治疗市场的成长和趋势

根据 Grand View Research, Inc. 的一份新报告，全球酒糟治疗市场预计到 2030 年将达到 31.2 亿美元。预计 2025 年至 2030 年期间复合年增长率为 7.1%。先进的配方和高发的疾病等多种因素预计将推动市场成长。

酒糟影响全球超过 4 亿人，全球成人盛行率估计为 5%。目前接受治疗的患者不到150万，而且疾病的诊断非常晚。这种疾病在女性中比男性更为常见，一些研究发现饮酒与更年期症状有关。由于没有明确的治疗方法方法，治疗方法方案主要集中于疾病管理。

酒糟治疗市场已经变得高度分散，由于多个专利到期，学名药占据了市场主导地位。酒糟是一种很容易被误诊的疾病，经常被误诊为痤疮。药品仿单标示外的使用导致了酒糟专用治疗药物的激烈竞争。

局部治疗仍是主要治疗方法。 2017年，外用产品占了60%以上的市场占有率。儘管预计在预测期内局部产品仍将保持对口服药物的领先地位，但市场正在经历模式转移，其推动力是人们对组合产品的倾向日益增加。

酒糟的治疗方案包括抗生素、α促效剂、类视色素、免疫抑制剂、皮质类固醇和抗高血压药物。抗生素被列为首选治疗药物，在 2017 年占据主导地位，预计这一趋势将持续到 2025 年。

酒糟治疗市场的成长得益于 Rhofade、Mirvaso、Oracea、MetroGel、Noritate 和 Finacea 等主要产品的强劲商业性销售。儘管学名药的渗透是一个限制因素，但由于有前景的研发线产品即将面世，全球市场的未来前景乐观。

酒糟治疗市场报告重点

  • 由于抗生素作为酒糟的一线治疗药物的地位，它在 2024 年占据了市场主导地位，收入份额为 51.3%。
  • 局部治疗领域在 2024 年占据了最大的收益占有率，并占据了市场主导地位。
  • 由于消费者意识高和医疗基础设施先进等多种因素，北美酒糟治疗市场预计将在 2024 年占据 38.7% 的最高收入份额。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3酒糟。

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析 – 波特五力分析
    • PESTLE分析

第 4 章酒糟治疗市场：药物类别业务分析

  • 2024 年及 2030 年药物类别市场占有率
  • 药品类别细分仪表板
  • 2018 年至 2030 年按药物类别分類的市场规模、预测和趋势分析
  • 抗生素
  • α-促效剂
  • 类视色素
  • 皮质类固醇
  • 免疫抑制剂
  • 其他的

第 5 章酒糟治疗市场：管理方法业务分析

  • 2024 年及 2030 年管理模式市场占有率
  • 管理模式细分仪表板
  • 2018 年至 2030 年按交付方式分類的市场规模、预测与趋势分析
  • 局部的
  • 口服

第 6 章酒糟治疗市场：按地区分類的估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030 年市场规模及预测趋势分析
  • 北美洲
    • 按国家/地区，2018 年至 2030 年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家/地区，2018 年至 2030 年
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 按国家/地区，2018 年至 2030 年
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 按国家/地区，2018 年至 2030 年
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • AbbVie Inc.
    • Bayer AG
    • Bausch Health Companies Inc.
    • Nestle Skin Health
    • Sol-Gel Technologies Ltd.
    • Mayne Pharma Group Limited
    • LEO Pharma A/S
    • Pfizer Inc.
    • Aclaris Therapeutics, Inc.
    • Galderma
Product Code: GVR-2-68038-739-1

Rosacea Treatment Market Growth & Trends:

The global rosacea treatment market size is expected to reach USD 3.12 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 7.1% from 2025 to 2030. Several factors such as an advanced formulations and high prevalence of the disease are forecasted to fuel the market growth.

Rosacea affects more than 400 million people worldwide and the global incidence among adults is estimated at 5%. Less than 1.5 million patients seek treatment, making it a highly underdiagnosed condition. This disease has a higher incidence in women than men, with several studies claiming a possible association between rosacea and menopause. In the absence of an absolute cure, treatment options are largely focused on management of the disease.

The market for rosacea treatment is majorly genericized due to multiple patent expiries, leading to a highly fragmented therapeutic landscape. Rosacea is an underdiagnosed condition and is frequently misdiagnosed as acne. Off-label use of therapeutics pose an intensely competitive space for rosacea-specific treatments.

Topical therapies remain the mainstay for treatment. Topical products captured more than 60% market share in 2017. Although topical items are expected to maintain their lead over oral medicines through the forecast period, the market is witnessing a paradigm shift supported by the increasing inclination towards combination products.

Therapeutic options available for rosacea treatment are antibiotics, alpha agonists, retinoids, immunosuppressants, corticosteroids, antihypertensive agents, and others. Antibiotics are prescribed for the first-line treatment, making them the dominant drug class in 2017-a trend expected to continue through 2025.

The rosacea treatment market growth is supported by strong commercial sales from key products such as Rhofade, Mirvaso, Oracea, MetroGel, Noritate, and Finacea. Although increased penetration of generic drugs is a constraining factor, the impending launch of several promising pipeline products indicate an optimistic future for the global market.

Rosacea Treatments Market Report Highlights:

  • The antibiotics segment dominated the market with a revenue share of 51.3% in 2024 due to their established role as first-line therapies for rosacea.
  • The topical segment dominated the market with the largest revenue share in 2024, which can be attributed to its convenience and effectiveness in treating localized symptoms.
  • North America rosacea treatment market held the highest revenue share of 38.7% in 2024 due to a combination of factors, including high consumer awareness and advanced healthcare infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Mode of Administration
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Rosacea Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Rosacea Treatment Market: Drug Class Business Analysis

  • 4.1. Drug Class Market Share, 2024 & 2030
  • 4.2. Drug Class Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2018 to 2030 (USD Billion)
  • 4.4. Antibiotics
    • 4.4.1. Antibiotics Market, 2018 - 2030 (USD Billion)
  • 4.5. Alpha Agonists
    • 4.5.1. Alpha Agonists Market, 2018 - 2030 (USD Billion)
  • 4.6. Retinoids
    • 4.6.1. Retinoids Market, 2018 - 2030 (USD Billion)
  • 4.7. Corticosteroids
    • 4.7.1. Corticosteroids Market, 2018 - 2030 (USD Billion)
  • 4.8. Immunosuppressants
    • 4.8.1. Immunosuppressants Market, 2018 - 2030 (USD Billion)
  • 4.9. Others
    • 4.9.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 5. Rosacea Treatment Market: Mode of Administration Business Analysis

  • 5.1. Mode of Administration Market Share, 2024 & 2030
  • 5.2. Mode of Administration Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Mode of Administration, 2018 to 2030 (USD Billion)
  • 5.4. Topical
    • 5.4.1. Topical Market, 2018 - 2030 (USD Billion)
  • 5.5. Oral
    • 5.5.1. Oral Market, 2018 - 2030 (USD Billion)

Chapter 6. Rosacea Treatment Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Rosacea Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Canada Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Europe
    • 6.5.1. Europe Rosacea Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Rosacea Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Latin America
    • 6.7.1. Latin America Rosacea Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8. MEA
    • 6.8.1. MEA Rosacea Treatment Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Rosacea Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. AbbVie Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Bayer AG
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Bausch Health Companies Inc.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Nestle Skin Health
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Sol-Gel Technologies Ltd.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Mayne Pharma Group Limited
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. LEO Pharma A/S
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Pfizer Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Aclaris Therapeutics, Inc.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Galderma
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global rosacea treatment market, by region, 2018 - 2030 (USD Billion)
  • Table 4 Global rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 5 Global rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 6 North America rosacea treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 7 North America rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 8 North America rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 9 U.S. rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 10 U.S. rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 11 Canada rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 12 Canada rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 13 Mexico rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 14 Mexico rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 15 Mexico rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 16 Europe rosacea treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 17 Europe rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 18 Europe rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 19 UK rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 20 UK rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 21 Germany rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 22 Germany rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 23 France rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 24 France rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 25 Italy rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 26 Italy rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 27 Spain rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 28 Spain rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 29 Norway rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 30 Norway rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 31 Denmark rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 32 Denmark rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 33 Sweden rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 34 Sweden rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 35 Asia Pacific rosacea treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 36 Asia Pacific rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 37 Asia Pacific rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 38 Japan rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 39 Japan rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 40 China rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 41 China rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 42 India rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 43 India rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 44 Australia rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 45 Australia rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 46 South Korea rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 47 South Korea rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 48 Thailand rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 49 Thailand rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 50 Latin America rosacea treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 51 Latin America rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 52 Latin America rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 53 Brazil rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 54 Brazil rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 55 Argentina rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 56 Argentina rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 57 Middle East & Africa rosacea treatment market, by country, 2018 - 2030 (USD Billion)
  • Table 58 Middle East & Africa rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 59 Middle East & Africa rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 60 South Africa rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 61 South Africa rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 62 Saudi Arabia rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 63 Saudi Arabia rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 64 UAE rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 65 UAE rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)
  • Table 66 Kuwait rosacea treatment market, by drug class, 2018 - 2030 (USD Billion)
  • Table 67 Kuwait rosacea treatment market, by mode of administration, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Rosacea treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Drug class outlook (USD Billion)
  • Fig. 10 Mode of administration outlook (USD Billion)
  • Fig. 11 Competitive landscape
  • Fig. 12 Rosacea treatment market dynamics
  • Fig. 13 Rosacea treatment market: Porter's five forces analysis
  • Fig. 14 Rosacea treatment market: PESTLE analysis
  • Fig. 15 Rosacea treatment market: Drug class segment dashboard
  • Fig. 16 Rosacea treatment market: Drug class market share analysis, 2024 & 2030
  • Fig. 17 Antibiotics market, 2018 - 2030 (USD Billion)
  • Fig. 18 Alpha agonists market, 2018 - 2030 (USD Billion)
  • Fig. 19 Retinoids market, 2018 - 2030 (USD Billion)
  • Fig. 20 Corticosteroids market, 2018 - 2030 (USD Billion)
  • Fig. 21 Immunosuppressants market, 2018 - 2030 (USD Billion)
  • Fig. 22 Others market, 2018 - 2030 (USD Billion)
  • Fig. 23 Rosacea treatment market: Mode of administration segment dashboard
  • Fig. 24 Rosacea treatment market: Mode of administration market share analysis, 2024 & 2030
  • Fig. 25 Topical market, 2018 - 2030 (USD Billion)
  • Fig. 26 Oral market, 2018 - 2030 (USD Billion)
  • Fig. 27 Rosacea treatment market revenue, by region
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 North America rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 30 U.S. country dynamics
  • Fig. 31 U.S. rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 32 Canada country dynamics
  • Fig. 33 Canada rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 34 Mexico country dynamics
  • Fig. 35 Mexico rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 36 Europe rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 37 UK country dynamics
  • Fig. 38 UK rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 39 Germany country dynamics
  • Fig. 40 Germany rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 41 France country dynamics
  • Fig. 42 France rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 43 Italy country dynamics
  • Fig. 44 Italy rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 45 Spain country dynamics
  • Fig. 46 Spain rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 47 Norway country dynamics
  • Fig. 48 Norway rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 49 Denmark country dynamics
  • Fig. 50 Denmark rosacea treatment market, 2018 - 2030 (USD Billion
  • Fig. 51 Sweden country dynamics
  • Fig. 52 Sweden rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 53 Asia Pacific rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 54 Japan country dynamics
  • Fig. 55 Japan rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 56 China country dynamics
  • Fig. 57 China rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 58 India country dynamics
  • Fig. 59 India rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 60 South Korea country dynamics
  • Fig. 61 South Korea rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 62 Australia country dynamics
  • Fig. 63 Australia rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 64 Thailand country dynamics
  • Fig. 65 Thailand rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 66 Latin America rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 67 Brazil country dynamics
  • Fig. 68 Brazil rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 69 Argentina country dynamics
  • Fig. 70 Argentina rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 71 MEA rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 72 South Africa country dynamics
  • Fig. 73 South Africa rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 74 Saudi Arabia country dynamics
  • Fig. 75 Saudi Arabia rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 76 UAE country dynamics
  • Fig. 77 UAE rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 78 Kuwait country dynamics
  • Fig. 79 Kuwait rosacea treatment market, 2018 - 2030 (USD Billion)
  • Fig. 80 Company categorization
  • Fig. 81 Company market position analysis
  • Fig. 82 Strategic framework